

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Covid-19 | D000086382 | — | U07.1 | — | 1 | 1 | — | — | 1 |
| Pneumonia | D011014 | EFO_0003106 | J18 | — | 1 | 1 | — | — | 1 |
| Inflammation | D007249 | MP_0001845 | — | — | 1 | 1 | — | — | 1 |
| Drug common name | Regramostim |
| INN | regramostim |
| Description | Regramostim is a protein pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Protein |
| Drug class | colony-stimulating factors: granulocyte macrophage colony-stimulating factors (GM-CSF); colony-stimulating factors: macrophage colony-stimulating factors (M-CSF) |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | — |
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL2107881 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | KR89Q40F01 (ChemIDplus, GSRS) |

